Arteris

As of 2026-10-09, Arteris has 0 tracked suppliers and 8 tracked customers in this dataset. The customer list here follows a shared pattern for this segment rather than being individually confirmed for Arteris — see /methodology.

Sourced from 1 reference — primary source — last verified 2026-06-12.

Network-on-chip (NoC) interconnect IP for SoC designs.

Ticker: NASDAQ: AIP
Headquarters: Sunnyvale
Founded: 2003
Revenue: $71M (FY2025) · +22.3% YoY
Net income: $-35M
Operating margin: -46.9%
Market position: niche
Value-chain segment: Semiconductor IP Licensing
Key products: NoC IP

About Arteris

Arteris, headquartered in United States, operates in the Semiconductor IP Licensing segment of the semiconductor & AI supply chain and is positioned as a market niche there. Its key products include NoC IP. wafergraph maps 8 tracked customers for Arteris across the value chain. It has a supply-chain criticality score of 50/100, with 236 companies downstream of it.

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP, system-on-chip (SoC) integration automation software and semiconductor hardware security assurance that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace and defense markets. The company specializes in the development and distribution of network-on-chip (NoC) interconnect intellectual property (IP) and SoC integration automation software products used for the underlying data movement within advanced semiconductors, including in support of growing AI workloads.

Role in the chain

Arteris is a market niche in EDA & IP (Semiconductor IP Licensing), headquartered in United States. Network-on-chip (NoC) interconnect IP for SoC designs.

Diligence questions

The dataset names 8 tracked customers for Arteris. How concentrated is demand among those names, and which of them have a documented second source in this graph?
Arteris is headquartered in United States. What jurisdiction, export-control or logistics risk sits at that HQ, versus at the fabs or plants the filings actually name?
Arteris trades as NASDAQ:AIP. What does the latest reported period say about capacity and backlog versus the graph position above?
Before treating any edge as a verified relationship, check the provenance labels on the company page and the method note at /methodology.

Full diligence pack for Arteris